Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$3.5 -8.38%
Market Cap
$278.8M
Price Target
Refer to Report
Volume
374.2K
52wk Range
$0.75 - $5.54
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.